2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Trust note

What this source is and what it can support

Summary

A guideline source that supports caution and individualized care in diabetes and related metabolic conditions.

Why this source matters

The 2019 ESC/EASD guideline on diabetes, pre-diabetes, and cardiovascular diseases is a strong supporting source for the safety part of this topic. The key reason it matters is that intermittent fasting is not just a weight-loss pattern; for people with diabetes, changing meal timing can interact with glucose control and medication use in ways that ordinary calorie reduction may not.

This source is rated high quality because it is a formal guideline from the European Society of Cardiology and the European Association for the Study of Diabetes, both authoritative bodies in cardiometabolic care. The guideline is meant to synthesize evidence and expert judgment for clinical practice, which makes it highly credible for identifying higher-risk situations even though it is not a direct fasting trial.

What this guideline supports is the idea that dietary advice for diabetes should be individualized and that timing of food intake can matter clinically. What it does not prove is that intermittent fasting is better than regular dieting for weight loss, or that any specific fasting schedule is safe for every person using glucose-lowering medication.

In the article, this source should mainly back the cautionary section: fasting can be reasonable for some people, but diabetes adds enough complexity that the decision should be made carefully, ideally with medical guidance.

What to look at in the source

Relevant parts

• Diabetes and cardiovascular risk management recommendations
• Lifestyle and individualized treatment framing
• Clinical context for medication-sensitive eating patterns

Key findings

• Dietary advice in diabetes should be individualized.
• Meal timing can have clinical relevance in people with diabetes.
• The source supports caution rather than fasting superiority claims.

Notable wording from the source

DOI: 10.1093/eurheartj/ehz486 The Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.

How much weight to give it

For most readers, the main question is not how this source is classified internally. It is whether this source deserves real weight in the answer. This one is best treated as a high quality guideline source.

This source is used to support the safety and supervision section, especially for people with diabetes or other cardiometabolic complexity. It does not establish that fasting is superior for weight loss, and it does not replace individualized medical advice for medication management.

The ESC and EASD are credible, specialty-level institutions with deep expertise in diabetes and cardiovascular risk. Their guidance is trustworthy for identifying where meal timing and medication use can make fasting a different question than ordinary dieting.

This guideline was stored because the question explicitly requires safety and suitability distinctions, especially for people with diabetes who may use glucose-lowering medication.

Limits to keep in mind

• The retrieved excerpt is general and not fasting-protocol-specific.
• It does not provide medication-by-medication fasting instructions.